Here’s the notice for “Blockade of receptor for advanced glycation end products in a model of type 1 diabetic leukoencephalopathy”:
The authors have formally requested to retract the above-titled paper, which was published online on 19 November 2012. The authors cite concerns that portions of Fig. 4 were submitted without knowledge of inherent errors or abnormalities that they recognized in retrospect after submission. Therefore, the article has been retracted so the authors can readdress the work and submit it for publication at a later time.
We’ve asked corresponding author Cory Toth, of the University of Calgary, what those errors were, and will update with anything we learn.
Update, 9 a.m. Eastern, 1/8/13: Toth responded to our request for comment:
While preparing for a subsequent work, it came to our attention that the luxol fast blue images in the image were representative of separate cohorts of mice not studied in the publication. Due to this carelessness, I asked for retraction while we ensured that other images were truly representative and to permit performance of new image acquisition.